{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:39:15Z","timestamp":1792715955510,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00678-0","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:32:59Z","timestamp":1785169979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal clinical and musculoskeletal ultrasound assessment after switching from oral to subcutaneous methotrexate in rheumatoid arthritis: a two-center real-world study"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7898-9134","authenticated-orcid":false,"given":"Masatsugu","family":"Komagamine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8793-4104","authenticated-orcid":false,"given":"Sari","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-3997","authenticated-orcid":false,"given":"Tetsuji","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-8863","authenticated-orcid":false,"given":"Minoru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5681-2432","authenticated-orcid":false,"given":"Masataka","family":"Komagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"10055","key":"678_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet"},{"issue":"7","key":"678_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St.Clair EW, Arayssi T, Carandang K, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924\u201339. https:\/\/doi.org\/10.1002\/acr.24596.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"678_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ard.2026.01.023","volume":"85","author":"JS Smolen","year":"2026","unstructured":"Smolen JS, Edwards CJ, Konzett V, Laskou F, Aletaha D, Caporali R, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. Ann Rheumatic Dis. 2026;85(6):991\u20131009. https:\/\/doi.org\/10.1016\/j.ard.2026.01.023.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"678_CR4","first-page":"645","volume":"31","author":"M Hoekstra","year":"2004","unstructured":"Hoekstra M, Haagsma CJ, Neef C, Proost J, Knuif A, van de Laar M. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol. 2004;31(4):645\u201348.","journal-title":"J Rheumatol"},{"issue":"8","key":"678_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/annrheumdis-2014-205228","volume":"73","author":"MH Schiff","year":"2014","unstructured":"Schiff MH, Jaffe JS, Freundlich B. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses \u226515 mg may be overcome with subcutaneous administration. Ann Rheumatic Dis. 2014;73(8):1549\u201351. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205228.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"678_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/mr\/roac156","volume":"33","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y. Subcutaneous injection of methotrexate: advantages in the treatment of rheumatoid arthritis. Mod Rheumatol. 2023;33(4):633\u201339. https:\/\/doi.org\/10.1093\/mr\/roac156.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"678_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/mr\/roaf093","volume":"36","author":"Y Shimomura","year":"2026","unstructured":"Shimomura Y, Iwata S, Matsumiya R, Kato T, Ueno K, Nishikawa T, et al. The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting. Mod Rheumatol. 2026;36(2):190\u201395. https:\/\/doi.org\/10.1093\/mr\/roaf093.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"678_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4103\/jmu.jmu_126_22","volume":"31","author":"CC Chen","year":"2023","unstructured":"Chen CC, Chen DY. The clinical utility of musculoskeletal ultrasound for disease activity evaluation and therapeutic response prediction in rheumatoid arthritis patients: a narrative review. J Med Ultrasound. 2023;31(4):275\u201381. https:\/\/doi.org\/10.4103\/jmu.jmu_126_22.","journal-title":"J Med Ultrasound"},{"key":"678_CR9","doi-asserted-by":"publisher","unstructured":"D\u2019Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce \u2014 part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3(1):e000428. https:\/\/doi.org\/10.1136\/rmdopen-2016-000428.","DOI":"10.1136\/rmdopen-2016-000428"},{"key":"678_CR10","doi-asserted-by":"publisher","unstructured":"Terslev L, Naredo E, Aegerter P, Wakefield RJ, Backhaus M, Balint P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open. 2017;3(1):e000427. https:\/\/doi.org\/10.1136\/rmdopen-2016-000427.","DOI":"10.1136\/rmdopen-2016-000427"},{"issue":"10","key":"678_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3899\/jrheum.181095","volume":"46","author":"GA Bruyn","year":"2019","unstructured":"Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, et al. OMERACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on. J Rheumatol. 2019;46(10):1388\u201393. https:\/\/doi.org\/10.3899\/jrheum.181095.","journal-title":"J Rheumatol"},{"issue":"12","key":"678_CR12","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1093\/rheumatology\/keac261","volume":"61","author":"E Silvagni","year":"2022","unstructured":"Silvagni E, Zandonella Callegher S, Mauric E, Chiricolo S, Schreiber N, Tullio A, et al. Musculoskeletal ultrasound for treating rheumatoid arthritis to target\u2014a systematic literature review. Rheumatol (Oxford). 2022;61(12):4590\u2013602. https:\/\/doi.org\/10.1093\/rheumatology\/keac261.","journal-title":"Rheumatol (Oxford)"},{"issue":"6","key":"678_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","volume":"72","author":"AN Colebatch","year":"2013","unstructured":"Colebatch AN, Edwards CJ, \u00d8stergaard M, van der Heijde D, Balint PV, D\u2019Agostino M-A, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheumatic Dis. 2013;72(6):804\u201314. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203158.","journal-title":"Ann Rheumatic Dis"},{"issue":"9","key":"678_CR14","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheumatism. 2010;62(9):2569\u201381. https:\/\/doi.org\/10.1002\/art.27584.","journal-title":"Arthritis Rheumatism"},{"key":"678_CR15","doi-asserted-by":"publisher","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u201394. https:\/\/doi.org\/10.1001\/jama.2013.281053.","DOI":"10.1001\/jama.2013.281053"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00678-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00678-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:01:44Z","timestamp":1792713704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00678-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00678-0","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol, including retrospective review of clinical data collected between April 2020 and March 2024, was approved by the Institutional Review Board of Iwate Medical University (approval number: 2024\u2013118). Written informed consent for participation and use of clinical data was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}